Counterfeit retatrutide pens: why there is no real one

A pre-filled "retatrutide pen" looks like a medicine. That is the point of it. But Eli Lilly has never sold retatrutide in a pen, or in any other form, to anyone outside a clinical trial. So every retatrutide pen on sale was filled by someone else, with something. This page explains what the UK raids found, why fake pens have put people in comas, and why looking at a pen tells you nothing about what is inside it.

There is no such thing as a real retatrutide pen

Wegovy and Mounjaro come in pens because they are licensed medicines made by pharmaceutical companies. Retatrutide is not. It is an investigational medicine that Lilly supplies only to the people taking part in its trials.^[1] Lilly has said it does not sell retatrutide to anyone, and in August 2026 it sued six businesses for selling products under its drug's name.^[2]

That gives you a simple rule. If a product is called a retatrutide pen, it is not a Lilly product. It cannot be, because Lilly has never made one for sale. Whoever filled it was not the company that developed the drug, was not working under a manufacturing licence, and was not inspected by anyone. What it contains is a separate question, covered on what is actually in the vials.

What the MHRA found in the UK

In October 2025 the MHRA raided a warehouse on an industrial estate outside Northampton. Officers found more than 2,000 finished retatrutide and tirzepatide pens ready to post, and tens of thousands of empty pens waiting to be filled. Alongside them were raw chemical ingredients, packaging, manufacturing equipment and about £20,000 in cash. The MHRA called it the largest seizure of trafficked weight-loss medicines recorded by any law-enforcement agency in the world.^[3]

Four months later a second site was found on a farm near Sleaford, with a linked house in Grantham. Nearly 2,000 doses, equipment and ingredients were seized.^[4] In May 2026 a third operation on a country estate near Northampton recovered about 12,000 doses and led to two arrests.^[5] The MHRA enforcement page has the full timeline.

The detail that matters here is the empty pens. A pen is a plastic casing with a cartridge inside. Anyone with a box of empty ones and a syringe can fill them with whatever they like, print a label, and post them. The pen is packaging. It does not tell you what went into it.

How trial product is made, and how a fake is made

Licensed medicines in the UK can only be made by a holder of a manufacturer's licence, under conditions that the MHRA inspects.^[8] Trial medicines are held to the same manufacturing standard. That system is what makes the numbers on the clinical trials pages mean something: every participant got the same thing, at the stated strength, free of contamination.

The MHRA's description of the seized products was blunt: "untested, unauthorised, and potentially deadly", with "no guarantees about what they contain", and "some may even be contaminated with toxic substances".^[3] The farm operation was, in the agency's words, "made with no regard for safety".^[4]

When the pen contains insulin

The clearest example of what a fake pen can do comes from semaglutide, not retatrutide. From 2023 the MHRA received Yellow Card reports about branded weight-loss pens that turned out to be counterfeit. Several were confirmed to contain insulin instead of the drug on the label. People without diabetes injected them, and some were admitted to hospital with hypoglycaemic shock, and in some cases coma.^[6] Some of those fakes had made it into two licensed UK wholesalers before being spotted.^[6]

In June 2024 the World Health Organization issued a global alert about falsified semaglutide products found in the UK, the United States and Brazil.^[7]

Insulin is cheap, comes in pen cartridges, and is a clear liquid. For someone filling empty pens it is an obvious thing to use. For someone without diabetes who injects it, it can be fatal. Low blood sugar in a person without diabetes is rare and always needs urgent medical attention.^[9]

Signs of low blood sugar

The NHS lists these symptoms of hypoglycaemia: feeling hungry, dizzy, anxious or irritable; sweating; shaking; tingling lips; palpitations; feeling tired or weak; blurred vision; and confusion. Severe low blood sugar can cause fits and unconsciousness.^[9] If these happen to someone who has just used an injected weight-loss product, treat it as an emergency.

Why appearance proves nothing

People sometimes ask how to tell a real pen from a fake. For retatrutide the answer is that there is no real one to compare against. But even for licensed drugs, looking is not enough:

• The insulin-filled pens were convincing enough to pass through licensed wholesalers, whose job includes checking stock.^[6]
• A pen filled from a bulk vial in a warehouse looks identical to one filled with saline, insulin or double-strength drug. The liquid is clear in every case.
• Labels, batch numbers, holograms and boxes are all printed. The Northampton site had "sophisticated packaging" equipment on the premises.^[3]
• The only way to know what is in a pen is laboratory analysis, and even that only tells you about the sample tested, not the one you hold.

That is why this site does not publish a checklist for spotting fakes. A checklist would give false confidence, and the products that pass it would be no safer. Anything that looks professional was made by someone who wanted it to.

Pens versus vials

Most products sold as retatrutide are freeze-dried powder in small vials rather than pens. Vials carry their own problems, mainly around identity, strength and contamination, which are covered on what is actually in the vials and injectables and infection. Pens add one more: the person filling them chose the liquid. Insulin, saline, the wrong drug or the right drug at the wrong strength all look the same through the window.